⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
HOWL News
Werewolf Therapeutics, Inc. Common Stock
Form 8-K
sec.gov
HOWL
Werewolf Therapeutics and Ambros Therapeutics Announce Merger Agreement and Concurrent Oversubscribed $150 million Private Placement
globenewswire.com
HOWL
Werewolf Therapeutics and Ambros Therapeutics Announce Merger Agreement and Concurrent Oversubscribed $150 Million Private Placement
globenewswire.com
HOWL
Form 8-K
sec.gov
HOWL
Form 8-K
sec.gov
HOWL
Werewolf Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Updates
globenewswire.com
HOWL
Form 8-K
sec.gov
HOWL
Werewolf Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Updates
globenewswire.com
HOWL
Form 8-K
sec.gov
HOWL
Werewolf Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates
globenewswire.com
HOWL